Can we prevent the development of lymphoedema?

Melanie Lewis, Nicola Drury, Nicole Gergich, Vaughan Keeley
11 February 2014

<p>The focus of this debate is the prevention of the development of overt, clinical lymphoedema in those at risk. Much of the literature has concentrated on reducing the risk of lymphoedema development after treatment for breast cancer. Some of this has related to refinements in surgical and radiotherapy techniques, such as sentinel node biopsy (Sener et al, 2001), which try to minimise damage to the lymphatic system. Other papers have described recommendations to reduce the likelihood of swelling after treatment. These are intended to prevent further damage to the lymphatic system, reduce the risk of infection and improve lymphatic drainage. The advice is mainly based on common sense with little research evidence to support it (Clark et al, 2005; Lymphoedema Framework, 2006). Following these recommendations may significantly alter the patient’s way of life and, therefore, it is important to identify which measures are the most effective, so that informed decisions can be made.</p>

Free for all healthcare professionals

Sign up to the Wounds Group journals





By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.